<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-OQKWBPBH</identifier><date>2002</date><creator>Jezeršek Novaković, Barbara</creator><relation>documents/doc/O/URN_NBN_SI_doc-OQKWBPBH_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-OQKWBPBH_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 44-46</format><identifier identifier_type="COBISSID_HOST">15750105</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-OQKWBPBH</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Onkološki inštitut</publisher><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Burkitt's Lymphoma</subject><subject language_type_id="slv">Ciklofosfamid</subject><subject language_type_id="eng">Cyclophosphamide</subject><subject language_type_id="eng">Diagnosis</subject><subject language_type_id="eng">Lymphoma, Non-Hodgkin's</subject><subject language_type_id="eng">Methotrexate</subject><subject language_type_id="slv">Metotreksat</subject><subject language_type_id="eng">Therapy</subject><title>Predstavitev bolnikov z malignimi limfomi</title></Record>